CEO Anne Wojcicki, who controls 49.75% of the voting rights, remains the sole board member of the San Francisco-based company ...

The company 23andMe is based out of San Francisco and is now left with a single board member, Wojcicki who controls 49.75 per ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

Turmoil at 23andMe, and a lawsuit alleging that GEDmatch shares data with Facebook, highlights how far your genetic ...

Once the domain of science fiction, neurotechnology is a reality with enormous implications for medicine and the digital ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...

Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her ...

A huge data breach followed by a plummeting valuation has stoked fears of a sale of 23andMe along with all of its customers' genetic data.